Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx

Filippo Ricciardiello; Michele Caraglia; Brigida Iorio; Teresa Abate; Mariarosaria Boccellino; Giuseppe Colella; Flavia Oliva; Pierpaolo Ferrise; Silvia Zappavigna; Mario Faenza; Giuseppe A. Ferraro; Giulio Sequino; Giovanni Francesco Nicoletti; Massimo Mesolella

doi:10.18632/oncotarget.21327

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx

Filippo Ricciardiello, Michele Caraglia _, Brigida Iorio, Teresa Abate, Mariarosaria Boccellino, Giuseppe Colella, Flavia Oliva, Pierpaolo Ferrise, Silvia Zappavigna, Mario Faenza, Giuseppe A. Ferraro, Giulio Sequino, Giovanni Francesco Nicoletti and Massimo Mesolella

PDF | HTML | How to cite

Oncotarget. 2017; 8:95791-95798. https://doi.org/10.18632/oncotarget.21327

Metrics: PDF 1202 views | HTML 3322 views | ?

Abstract

Filippo Ricciardiello1, Michele Caraglia3, Brigida Iorio2, Teresa Abate1, Mariarosaria Boccellino3, Giuseppe Colella4, Flavia Oliva1, Pierpaolo Ferrise1, Silvia Zappavigna3, Mario Faenza4, Giuseppe A. Ferraro4, Giulio Sequino1, Giovanni Francesco Nicoletti4 and Massimo Mesolella2

1Division of Otolaryngology, “A. Cardarelli” Hospital, Naples, Italy

2Department of Neurological, Reproductive and Odontostomatological Sciences, University “Federico II” of Naples, Naples, Italy

3Department of Biochemistry, Biophysics and General Pathology, University of Campania “L. Vanvitelli”, Naples, Italy

4Department of Medical, Surgical and Dental Specialties, University of Campania “L. Vanvitelli”, Naples, Italy

Correspondence to:

Michele Caraglia, email: [email protected], [email protected]

Keywords: laryngea lbasaloid squamocellular carcinoma (BSCC); prognosis of laryngeal basaloid squamous cell carcinoma; mortality of laryngeal BSCC; loco-regional recurrence in laryngeal BSCC

Received: July 26, 2017 Accepted: August 23, 2017 Published: September 28, 2017

ABSTRACT

Basaloid squamous cell carcinoma (BSCC) is a rare, aggressive and distinct variant of squamous cell carcinoma (SCC) of the upper respiratory and digestive tract. We have evaluated disease specific survival (DSS) and overall survival (OS) through Kaplan-Meier method and mortality risk through univariate statistical analysis of Cox in 42 cases of BSCC and other 42 of laryngeal SCC (LSCC) matched for both age and sex. We demonstrated that laryngeal BSCC is a more aggressive tumor than LSCC as is associated to higher nodal recurrence of pathology (5 vs 2 patients, overall risk, OR 2.7), a reduced survival (median survival 34 vs 40 months, OR 3.2 for mortality); in addition, basaloid patients have a higher risk to be affected by second primary tumors (13 vs 3 patients, OR 5.8) and a higher probability to die for this second tumor (Hazard Risk, HR 4.4). The analysis of survival shows an increased mortality risk concurrent with the parameters assessed by univariate analyses that assume a predictive and statistical significance in second tumor and grading in basaloid LSSC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21327

Publication Alerts

Research Papers:

Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx

Abstract